Foundation News

The Crohn’s & Colitis Foundation announced today that it has received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to improve the urgent care management of Crohn’s disease through IBD Qorus®, the Foundation’s flagship quality of care program.

Progenity, Inc., a biotechnology company with an established track record of success developing and commercializing molecular testing products, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to further develop Progenity’s first-in-class oral Drug Delivery System (DDS) for delivery of targeted therapeutics for inflammatory bowel disease (IBD).

<-->

We are excited to announce the2021 Rising Healthcare Leader in IBD- Dr. Sarah Flier!

My son Robert was diagnosed with Crohn’s disease when he was 15. He is now 21 and in remission. I give so much credit to the Crohn’s & Colitis Foundation for all the research and fundraising that they have done over the years...

Check out ourApril 2021 Chapter Newsletter

Today our volunteer spotlights will include special event volunteers. With that in mind, we want to introduce Drs.

Today our volunteer spotlights will include special event volunteers. With that in mind, we want to introduce Drs.

Today, we’re highlighting some of our Georgia Support Group facilitators!